Morphosys AG Gross Profit

Morphosys AG (MOR) currently reports a gross profit of $160M as of March 2024. That compares with $240M in the prior-year period — down 31.6% year over year. That is below the Healthcare sector average of $65B. Use the charts on this page to explore Morphosys AG's gross profit history and peer comparisons.

Morphosys AG's gross profit decreased from $240M to $160M — a 31.6% year-over-year decrease (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Morphosys AG's gross profit of $160M is lower than the Healthcare sector average of $65B. That is roughly 99.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Morphosys AG reported $160M in gross profit as of March 2024. That compares with $240M in the prior-year period — down 31.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current gross profit of $160M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $65B. From there, open related valuation or income-statement pages for Morphosys AG, and consider following MOR for alerts when major investors trade the stock.